We introduced the Enhanced Service Specification: COVID-19 vaccination programme 2020/21 which enables general practitioner (GP) practices to vaccinate unregistered patients within their eligible priority cohort.<\/p>
For individuals not registered with a GP, the National Health Service and local partners will ensure they are offered appropriate support to receive the vaccine and avoid inequalities in access. This includes making the vaccination available from a range of settings. We are also working with community leaders and partners on initiatives to encourage people to register with a GP and with councils to ensure targeted support is included in local area vaccination plans for unregistered patients.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"} } , "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"} , "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"} , "dateOfAnswer" : {"_value" : "2021-07-07", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-07-07T11:10:02.903Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2021-06-29", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what (a) steps he is taking and (b) plans he has to ensure that people not registered with a GP are able to access covid-19 vaccines.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4006", "label" : {"_value" : "Biography information for Dr Matthew Offord"} } , "tablingMemberConstituency" : {"_value" : "Hendon"} , "tablingMemberPrinted" : [{"_value" : "Dr Matthew Offord"} ], "uin" : "24164"} , {"_about" : "http://data.parliament.uk/resources/1303068", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1303068/answer", "answerText" : {"_value" : "
The UK is proud to have joined COVAX, an international initiative to support the discovery, manufacture, and fair distribution of COVID-19 vaccines across the world.<\/p>
<\/p>
COVAX is an international alliance co-led by the Global Vaccine Alliance (Gavi), the Coalition for Epidemic Preparedness Innovations (CEPI) and World Health Organization (WHO), with participation from over 180 countries.<\/p>
<\/p>
The UK is one of the largest bilateral donors to the COVAX Advanced Market Commitment (AMC), which will give lower and middle-income countries equitable access to vaccines that are developed. The UK has committed £548 million to the COVAX AMC.<\/p>
<\/p>
COVAX has so far shipped over 29 million COVID-19 vaccines to 46 countries.<\/p>
<\/p>
Full details of UK\u2019s GAVI commitments can be found here at https://www.gavi.org/investing-gavi/funding/donor-profiles/united-kingdom<\/a>.<\/p> <\/p> Full details of COVAX\u2019s rollout can be found here at https://www.gavi.org/covax-vaccine-roll-out<\/a>.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-03-24", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-03-24T17:19:30.263Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "201"}
, "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"}
, "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"}
, "date" : {"_value" : "2021-03-16", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, (a) how many and (b) which countries are being assisted by the UK to procure covid-19 vaccines.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4006", "label" : {"_value" : "Biography information for Dr Matthew Offord"}
}
, "tablingMemberConstituency" : {"_value" : "Hendon"}
, "tablingMemberPrinted" : [{"_value" : "Dr Matthew Offord"}
], "uin" : "169837"}
, {"_about" : "http://data.parliament.uk/resources/1285355", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1285355/answer", "answerText" : {"_value" : " Public Heath England\u2019s surveillance strategy will monitor how effective the vaccine is at protecting against a range of outcomes, including infection, symptomatic disease, hospitalisations, mortality, and onward transmission. The surveillance strategy is available at the following link:<\/p> https://www.gov.uk/government/publications/covid-19-vaccine-surveillance-strategy<\/a><\/p> The National Institute for Health Research (NIHR) and UK Research and Innovation are jointly funding the UK Coronavirus Immunology Consortium to address key questions around the immune system\u2019s response to COVID-19. The NIHR\u2019s Health Protection Research Unit in Respiratory Infections is also looking at the size and longevity of the immune response.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-03-05", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-03-05T16:07:46.27Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-02-09", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what plans his Department has to implement a long term study of immune responses in people vaccinated against covid-19.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4006", "label" : {"_value" : "Biography information for Dr Matthew Offord"}
}
, "tablingMemberConstituency" : {"_value" : "Hendon"}
, "tablingMemberPrinted" : [{"_value" : "Dr Matthew Offord"}
], "uin" : "151686"}
, {"_about" : "http://data.parliament.uk/resources/1285357", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1285357/answer", "answerText" : {"_value" : " Public Health England has published early estimates of vaccine effectiveness which includes the United Kingdom variant of concern which is available at the following link:<\/p>